Pharmaceutical firm Cipla is all set to launch Favipiravir, developed by the Council of Scientific and Industrial Research (CSIR) in a cost-effective process, for the treatment of COVID-19 patients,...
Home »
NDTV News - India-news
» Cipla Set To Launch Favipiravir Drug For Treatment Of COVID Patients
No comments:
Post a Comment